1. Academic Validation
  2. Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709

Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709

  • Diagn Microbiol Infect Dis. 1992 Sep-Oct;15(7):621-5. doi: 10.1016/0732-8893(90)90040-3.
W Brumfitt 1 J M Hamilton-Miller
Affiliations

Affiliation

  • 1 Department of Medical Microbiology, Royal Free Hospital School of Medicine, London, UK.
Abstract

The Oxazolidinone compound E3709, which contains a 4-pyridyl group, was found to be more active in vitro than Other members of this series, such as DuP 721. MIC90 for staphylococci(including methicillin-resistant isolates), streptococci (including Enterococcus faecalis), Clostridia, and diphtheroids was less than 0.5 micrograms/ml. Haemophilus influenzae, Moraxella catarrhalis, and Bacteroides fragilis were less susceptible, with an MIC90 between 2 and 8 micrograms/ml. E3709 MICs of Gram-negative species ranged from 100 to greater than 1000 micrograms/ml. At a concentration of 10 micrograms/ml, E3709 was bactericidal for selected Gram-positive species. A postantibiotic effect of 3 hr was observed against staphylococci. Resistance to E3709 was not detected.

Figures
Products